75 related articles for article (PubMed ID: 6145937)
1. Screening for nasopharyngeal carcinoma.
Lancet; 1984 Jul; 2(8393):20-2. PubMed ID: 6145937
[No Abstract] [Full Text] [Related]
2. Anti-EBV antibody titers in Italian patients with nasopharyngeal carcinoma.
Pirodda E; Caliceti U; Testoni S
J Exp Pathol; 1987; 3(4):479-83. PubMed ID: 2842481
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma].
Mendoza J; Rojas A; de la Rosa M; Amador JM; Expósito J; Esquivias J
Med Clin (Barc); 1991 Nov; 97(16):609-11. PubMed ID: 1662737
[TBL] [Abstract][Full Text] [Related]
4. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma].
Vera Sempere FJ
Med Clin (Barc); 1992 May; 98(19):758-9. PubMed ID: 1318986
[No Abstract] [Full Text] [Related]
5. Monoclonal antibodies in Epstein-Barr virus-related nasopharyngeal carcinoma: prognostic and therapeutic implications.
Levine PH; Pearson GR
J Exp Pathol; 1987; 3(4):329-33. PubMed ID: 2842473
[No Abstract] [Full Text] [Related]
6. Epstein-Barr virus serology in the control of nasopharyngeal carcinoma.
Levine PH; Connelly RR; Milman G; Easton J
Cancer Detect Prev; 1988; 12(1-6):357-62. PubMed ID: 2846170
[TBL] [Abstract][Full Text] [Related]
7. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma.
Sam CK; Prasad U; Pathmanathan R
Eur J Surg Oncol; 1989 Aug; 15(4):357-60. PubMed ID: 2547665
[TBL] [Abstract][Full Text] [Related]
8. [Nasopharyngeal carcinoma (NPC) mortality rate in two districts of Guangdong Province and their relation to IgA antibody level against EB virus capsid antigen].
Zong YS
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):103-5. PubMed ID: 1319889
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between natural cytotoxicity activity, Epstein-Barr virus (EBV) antibody titer and clinical status in nasopharyngeal carcinoma patients].
Mu M
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(1):46-9. PubMed ID: 2856431
[No Abstract] [Full Text] [Related]
10. [A study of the practical value of the immunoenzyme method in seroepidemiological field surveys].
Wu JM
Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Apr; 9(2):107-10. PubMed ID: 2842055
[No Abstract] [Full Text] [Related]
11. The genetic and antigenic basis for the IgA antibody response to Epstein-Barr viral capsid antigen.
Ng MH; Ho HC; Kwan HC
IARC Sci Publ (1971); 1978; (20):449-58. PubMed ID: 215527
[No Abstract] [Full Text] [Related]
12. Nasopharyngeal mucosal changes in EB virus VCA-IgA antibody positive persons.
Li EJ; Tan BF; Zeng Y; Wang PZ; Zhong JM; Deng H; Zhu CS; Wei JN; Pan WJ
Chin Med J (Engl); 1985 Jan; 98(1):25-30. PubMed ID: 2988864
[No Abstract] [Full Text] [Related]
13. A prospective evaluation of patients with nasopharyngeal carcinoma: an overview.
Neel HB
J Otolaryngol; 1986 Jun; 15(3):137-44. PubMed ID: 3014165
[TBL] [Abstract][Full Text] [Related]
14. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547
[TBL] [Abstract][Full Text] [Related]
15. [Serologic screening on nasopharyngeal cancer in 338,868 persons in 21 cities and counties of Guangxi Region, China].
Deng H; Zhao Z; Zhang Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):342-3. PubMed ID: 8697937
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
Henle W; Henle G; Ho JH
IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
[No Abstract] [Full Text] [Related]
17. Screening for NPC.
Chan SH
Ann Acad Med Singap; 1989 Jan; 18(1):80-2. PubMed ID: 2712525
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr-specific IgA in nasopharyngeal cancer.
Lancet; 1978 Jun; 1(8078):1345-6. PubMed ID: 78104
[No Abstract] [Full Text] [Related]
19. [Application of immunoenzymic method and immunoautoradiographic method for the mass survey of nasopharyngeal carcinoma (author's transl)].
Zeng Y; Liu Y; Liu CR; Chen SW; Wei JE; Zhu JS; Zai HJ
Zhonghua Zhong Liu Za Zhi; 1979; 1(1):2-7. PubMed ID: 233230
[No Abstract] [Full Text] [Related]
20. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.
Kottaridis SD; Goula I; Kiparissiadis P
Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
